Adherence to antiretroviral treatment and correlation with risk of hospitalization among commercially insured HIV patients in the United States (Q34181784)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Adherence to antiretroviral treatment and correlation with risk of hospitalization among commercially insured HIV patients in the United States	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

31 July 2017

Adherence to antiretroviral treatment and correlation with risk of hospitalization among commercially insured HIV patients in the United States (English)

1 reference

Europe PubMed Central

31 July 2017

anti-retroviral agent

0 references

0 references

hospitalization

1 reference

based on heuristic

inferred from title

United States of America

1 reference

based on heuristic

inferred from title

Michael J Mugavero

3

object named as

Michael Mugavero

1 reference

Europe PubMed Central

31 July 2017

author name string

Paul E Sax

1

1 reference

Europe PubMed Central

31 July 2017

Juliana L Meyers

2

1 reference

Europe PubMed Central

31 July 2017

Keith L Davis

4

1 reference

Europe PubMed Central

31 July 2017

language of work or name

0 references

publication date

24 February 2012

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

7

1 reference

Europe PubMed Central

31 July 2017

2

1 reference

Europe PubMed Central

31 July 2017

e31591

1 reference

Europe PubMed Central

31 July 2017

copyright license

Creative Commons Attribution 4.0 International

24 February 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286454

5 July 2018

Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286454

5 July 2018

A single tablet regimen is associated with higher adherence and viral suppression than multiple tablet regimens in HIV+ homeless and marginally housed people

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286454

5 July 2018

Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286454

5 July 2018

One-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286454

5 July 2018

The cost and incidence of prescribing errors among privately insured HIV patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286454

5 July 2018

Better adherence with once-daily antiretroviral regimens: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286454

5 July 2018

Class-sparing regimens for initial treatment of HIV-1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286454

5 July 2018

Pilot study of a novel short-cycle antiretroviral treatment interruption strategy: 48-week results of the five-days-on, two-days-off (FOTO) study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286454

5 July 2018

Methods for evaluation of medication adherence and persistence using automated databases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286454

5 July 2018

Pharmacy-based assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDS and death

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286454

5 July 2018

Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286454

5 July 2018

Progress in HIV therapeutics and the challenges of adherence to antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286454

5 July 2018

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286454

5 July 2018

Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286454

5 July 2018

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286454

5 July 2018

Effect of Medication Adherence on Survival of HIV-Infected Adults Who Start Highly Active Antiretroviral Therapy When the CD4+ Cell Count Is 0.200 to 0.350 × 109 cells/L

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0031591

21 January 2018

Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0031591

21 January 2018

Simplification of antiretroviral therapy to a single-tablet regimen consisting of efavirenz, emtricitabine, and tenofovir disoproxil fumarate versus unmodified antiretroviral therapy in virologically suppressed HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0031591

21 January 2018

Patient-reported outcomes in virologically suppressed, HIV-1-Infected subjects after switching to a simplified, single-tablet regimen of efavirenz, emtricitabine, and tenofovir DF.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0031591

21 January 2018

Adherence to combined Lamivudine + Zidovudine versus individual components: a community-based retrospective medicaid claims analysis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0031591

21 January 2018

Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0031591

21 January 2018

Randomized, phase 2 evaluation of two single-tablet regimens elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for the initial treatment of HIV infection

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0031591

21 January 2018

Nonadherence increases the risk of hospitalization among HIV-infected antiretroviral naive patients started on HAART.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0031591

21 January 2018

Efficacy and safety of rilpivirine (TMC278) versus efavirenz at 48 weeks in treatment-naive HIV-1-infected patients: pooled results from the phase 3 double-blind randomized ECHO and THRIVE Trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286454

28 October 2018

Factors associated with complete adherence to HIV combination antiretroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22384040

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0031591

1 reference

Europe PubMed Central

31 July 2017

2012PLoSO...731591S

0 references

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34181784&oldid=1874169030"